Cellbion (308430)

KOSDAQ · 13,260 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

15,00025,00035,000 H 40,150L 10,570 25.0826.0526.08
Mkt Cap
171.1B
PBR
7.51
52W
10K~40K

Cellbion operates in the Pharmaceuticals sector.

Legal name: Cellbion Co., Ltd

As of the Aug 26, 2026 close, the market capitalization was 171.1 billion KRW, with a P/B of 7.51.

These figures can be verified in the DART filing (receipt no. 20260320001329).

Checks

3 applicable out of 8 items

Check details →

Recent Filings

Semi-Annual Report (2026.06)

All filings →

Checks

3 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.05% potential dilution.
Capital Increase: 1 capital-increase filing(s) in the last 180 days. [source]

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Recent Filings

DateFiling
2026-08-13Semi-Annual Report (2026.06)